Advertisement

U.S. markets open in 35 minutes

S&P Futures
3,716.50
-40.25(-1.07%)
Dow Futures
29,758.00
-224.00(-0.75%)
Nasdaq Futures
11,366.75
-175.00(-1.52%)
Russell 2000 Futures
1,741.80
-16.30(-0.93%)
Crude Oil
89.27
+0.82(+0.93%)
Gold
1,710.50
-10.30(-0.60%)

Advertisement

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

31.95

+0.02

(+0.06%)

At close: 04:00PM EDT

31.95

0.00

(0.00%)

After hours:

04:01PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	31.93
Open	31.81
Bid	31.50 x 1800
Ask	0.00 x 1300
Day's Range	31.77 - 32.07
52 Week Range	17.20 - 34.38
Volume	137,932
Avg. Volume	592,785

Market Cap	1.398B
Beta (5Y Monthly)	0.29
PE Ratio (TTM)	32.60
EPS (TTM)	0.98
Earnings Date	Nov 10, 2022 - Nov 14, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Feb 01, 2019
1y Target Est	34.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

25% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VIVO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Meridian Bioscience Inc.
VIVO: Lowering target price to $33.00MERIDIAN BIOSCIENCE INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
9 days agoArgus Research

All

Motley Fool
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
Most investors would like to see their stock portfolio grow significantly, especially if they have quite a few years left until retirement. Alphabet (NASDAQ: GOOG), Vertex Pharmaceuticals (NASDAQ: VRTX), Eli Lilly and Company (NYSE: LLY), and Meridian Bioscience (NASDAQ: VIVO) all show solid potential to grow your investments significantly. Alphabet's stock has risen 105% over the past five years.
- Alphabet Leaves a Huge Market
  TheStreet.com
- Better Buy: Alphabet vs. Apple
  Motley Fool
Zacks
Meridian Bioscience (VIVO) Meets Q3 Earnings Estimates
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 0% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS
Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2022.